The FTC has cleared from liability a pharmaceuticals firm which, just before the expiry of a patent based upon one ingredient of a drug, filed an additional patent for the drug on the basis of another active principle of the drug.
初审法院免除了一家制药公司的责任，该公司在一种药物的一项成分的专利到期之前，又根据该药物的另一项主要成分申请该药物的专利。